Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00287196
What this trial is testing

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Who this might be right for
Malignant MelanomaLymph Node Disease
Trans Tasman Radiation Oncology Group 250
Testing effectiveness (Phase 2)Study completedNCT00665470
What this trial is testing

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Who this might be right for
Skin CancerMetastatic Melanoma
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT01037790
What this trial is testing

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Who this might be right for
Adult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more
Abramson Cancer Center at Penn Medicine 304
Early research (Phase 1)Study completedNCT00005617
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

Who this might be right for
Melanoma
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00003060
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Louisiana State University Health Sciences Center Shreveport 6
Not applicableStudy completedNCT02143999
What this trial is testing

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 403
Testing effectiveness (Phase 2)Ended earlyNCT00509496
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

Who this might be right for
Skin CancerMelanoma
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT01253564
What this trial is testing

RO5185426 in Previously Treated Melanoma Patients With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Testing effectiveness (Phase 2)Ended earlyNCT03430947
What this trial is testing

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases

Who this might be right for
Malignant Melanoma Stage IVBRAF V600 MutationBrain Metastases
Technische Universität Dresden 20
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01435369
What this trial is testing

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Medivation, Inc. 103
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00855452
What this trial is testing

Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors

Who this might be right for
Metastatic Breast CancerMalignant MelanomaRenal Cell Cancer+1 more
Hadassah Medical Organization 20
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00026520
What this trial is testing

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network
Next Page